Company: TAK
Filing Date: 2025-07-02
Form Type: 6-K
Source: 0001395064-25-000111
Chunk: 1

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-07-02
Form: 6-K
Chunk 1
---
900% Guaranteed Notes due 2055                                                                                                                                                         |

The registrant hereby incorporates the Exhibits to this report on Form 6-K by reference into the prospectus that forms a part of the Registration Statement on Form F-3 (File Nos. 333-288301 and 333-288301-01) of the registrant and Takeda U.S. Financing, Inc., filed with the Securities and Exchange Commission on June 25, 2025.

### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| Date: July 2, 2025 |     | Takeda Pharmaceutical Company Limited 
 By:                                   |     | /s/ Norimasa Takeda                               |
|:-------------------|:----|:--------------------------------------|:----|:--------------------------------------------------|
|                    |     |                                       |     | Norimasa Takeda                                   |
|                    |     |                                       |     | Chief Accounting Officer and Corporate Controller |